# Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer

> **NCT00411151** · PHASE2 · COMPLETED · sponsor: **Johannes Gutenberg University Mainz** · enrollment: 52 (actual)

## Conditions studied

- Gastric Adenocarcinoma
- Barrett Esophagus

## Interventions

- **DRUG:** Sunitinib-Malate

## Key facts

- **NCT ID:** NCT00411151
- **Lead sponsor:** Johannes Gutenberg University Mainz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2011-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411151, "Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00411151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*